Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG:2196)
21.48
+0.22 (1.03%)
At close: Dec 5, 2025
HKG:2196 Market Cap
HKG:2196 has a market cap or net worth of 74.33 billion as of December 5, 2025. Its market cap has increased by 4.73% in one year.
Market Cap
74.33B
Enterprise Value
113.98B
Revenue
43.22B
Ranking
n/a
PE Ratio
20.72
Stock Price
21.48
Market Cap Chart
Since August 9, 2005, HKG:2196's market cap has increased from 4.19B to 74.33B, an increase of 1,672.03%. That is a compound annual growth rate of 15.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 74.33B | 16.91% |
| Dec 31, 2024 | 63.58B | -6.29% |
| Dec 29, 2023 | 67.85B | -30.95% |
| Dec 30, 2022 | 98.27B | -29.69% |
| Dec 31, 2021 | 139.76B | -6.44% |
| Dec 31, 2020 | 149.39B | 105.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 284.43B |
| Hansoh Pharmaceutical Group Company | 243.25B |
| JD Health International | 196.41B |
| Innovent Biologics | 157.33B |
| WuXi Biologics | 126.66B |
| Sino Biopharmaceutical | 120.67B |
| Akeso | 110.17B |
| Sichuan Kelun-Biotech Biopharmaceutical | 102.18B |